RETINALGENIX TECHNOLOGIES INC.

Highlights RetinalGenix Technologies Inc.

Equities

RTGN

US76133Y1055

Market Closed - OTC Markets Other stock markets 11:17:02 22/02/2024 pm IST			5-day change	1st Jan Change
3.5 ^USD	+12.90%		-.--%	+13.27%

20/05	RetinalGenix Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04	RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RetinalGenix Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	20/05	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04	CI
RetinalGeniX?? Technologies Inc. Contracts with Medsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	26/12	CI
RetinalGenix Technologies Inc. Appoints Stephen Tannenbaum to the Business Advisory Board	29/11	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
RetinalGeniX Technologies Inc. Announces the Submission of Two Provisional Patent Applications for Investigational Therapeutic Drugs	09/11	CI
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam? Image Visualization Device	08/11	CI
RetinalGeniX Technologies Inc. Announces Institutional Review Board Approves to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	31/23/31	CI
RetinalGenix Technologies Inc. Appoints Fred Chasalow to the Medical Advisory Board of DNA-GPS	28/23/28	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/23/19	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	18/22/18	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	20/22/20	CI
RetinalGenix Technologies Inc. acquired DNA/GPS Inc. from Lawrence Perich for $14 million.	06/22/06	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	16/22/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer